Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

3.27
Delayed Data
As of Sep 23
 -0.03 / -0.91%
Today’s Change
1.50
Today|||52-Week Range
5.44
+6.51%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.30
Today’s open3.26
Day’s range3.19 - 3.34
Volume648,989
Average volume (3 months)1,893,041
Market cap$313.5M
Dividend yield--
Data as of 09/23/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+23.39%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.04+0.32%
LNTHLantheus Holdings In...-0.58-6.39%
OXFDOxford Immunotec Glo...-0.03-0.25%
CLDXCelldex Therapeutics...+0.11+2.96%
Data as of 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Search for Jobs